Letoval 2.5mg Tablet
  1. Home
  2. Pharma Products
  3. Sun Pharmaceutical Industries Ltd
  4. Letoval 2.5mg Tablet

Letoval 2.5mg Tablet

Letoval 2.5 mg Tablet contains letrozole 2.5 mg, a non-steroidal aromatase inhibitor used as hormone therapy for breast cancer. It is primarily used for hormone receptor-positive breast cancer in postmenopausal women. The tablet is taken orally according to the treatment plan prescribed by a qualified healthcare professional.

BUY NOW

Category

Letrozole works by inhibiting the aromatase enzyme, which reduces estrogen production in the body. This reduction in estrogen can help slow or stop the growth of hormone-dependent breast cancer cells. Letoval 2.5 mg Tablet is manufactured by Sun Pharmaceutical Industries Ltd and is available in a 5-tablet strip. It may be used as initial, adjuvant, or extended therapy depending on the patient’s clinical condition and treatment plan.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Therapeutic Class Aromatase Inhibitor
Route of Administration Oral
Pack Size 5 tablets

Product Also Known As

Letoval 2.5 mg Tablet, Letoval 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole 2.5mg Tablet, Letrozole Anticancer Tablet, Letrozole Breast Cancer Tablet, Aromatase Inhibitor Tablet